Management of Septic Shock

References

• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–10.
   PubMed Web of Science ®Google Scholar
• ACCP-SCCM Consensus Conference. Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–74.
   PubMedGoogle Scholar
• Vincent JL. Sepsis definitions. Lancet Infect Dis 2002; 2: 135.
   PubMed Web of Science ®Google Scholar
• Task Force of the American College of Critical Care Medicine SoCCM. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 27: 639–60.
   PubMedGoogle Scholar
• Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77.
   PubMed Web of Science ®Google Scholar
• Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996; 171: 221–6.
   PubMed Web of Science ®Google Scholar
• Weil MH, Shubin H. The "VIP" approach to the bedside management of shock. JAMA 1969; 207: 337–40.
   PubMed Web of Science ®Google Scholar
• Martin GS, Bernard GR. Airway and lung in sepsis. Intensive Care Med 2001; 27 Suppl 1: S63–79.
   Google Scholar
• Rackow EC, Falk JL, Fein IA, Siegel JS, Pacicman MI, Haupt MT, et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983; 11: 839–50.
   PubMed Web of Science ®Google Scholar
• Choi PT, Yip G, Quinonez LG, Cook DJ Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200–10.
   PubMed Web of Science ®Google Scholar
• Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD, Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemor-rhagic shock. J Immunol 1998; 161: 6288–96.
   PubMedGoogle Scholar
• Junger WG, Hoyt DB, Davis RE, Herdon-Remelius C, Namiki S, Junger H, et al. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest 1998; 101: 2768–79.
   PubMed Web of Science ®Google Scholar
• Oreopoulos GD, Bradwell S, Lu Z, Fan J, Khadaroo R, Marshall JC, et al. Synergistic induction of IL-b by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages. Surgery 2001; 130: 157–65.
   PubMedGoogle Scholar
• Coimbra R, Hoyt DB, Junger WG, Angle N, Wolf P, Loomis W, et al. Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma 1997; 42: 602–6.
   PubMedGoogle Scholar
• Oi Y, Aneman A, Svensson M, Ewert S, Dahlqvist M, Haljamae H. Hypertonic saline-dextran improves intestinal perfusion and survival in porcine endotoxin shock. Crit Care Med 2000; 28: 2843–50.
   PubMed Web of Science ®Google Scholar
• de Carvalho H, Matos JA, Bouskela E, Svensjo E. Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran. Shock 1999; 12: 75–80.
   PubMedGoogle Scholar
• Assalia A, Bitterman H, Hirsh TM, Krausz MM. Influence of hypertonic saline on bacterial translocation in controlled hemorrhagic shock. Shock 2001; 15: 307–11.
   PubMedGoogle Scholar
• Maciel F, Mook M, Zhang H, Vincent JL. Comparison of hypertonic with isotonic saline hydroxyethyl starch solution on oxygen extraction capabilities during endotoxic shock. Shock 1998; 9: 33–9.
   PubMedGoogle Scholar
• Rizoli SB, Rotstein OD, Sibbald WJ. The immunological effects of hypertonic saline. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Heidelberg: Springer; 2002: 446–53.
   Google Scholar
• Cochrane Injuries Group. Human albumin administration in critically ill patients: systematic review of randomized con-trolled trials. Br Med J 1998; 317: 235–40.
   PubMed Web of Science ®Google Scholar
• Wilkes MM, Navickis R J. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135: 149–64.
   PubMed Web of Science ®Google Scholar
• Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994; 77: 1507–18.
   PubMed Web of Science ®Google Scholar
• Castro VJ, Astiz ME, Rackow EC. Effect of crystalloid and colloid solutions on blood rheology in sepsis. Shock 1997; 8: 104–7.
   PubMedGoogle Scholar
• Boldt J, Muller M, Mentges D, Papsdorf M, Hempehnann G. volume therapy in the critically ill: is there a difference? Intensive Care Med 1998; 24: 28–36.
   Google Scholar
• Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911–6.
   PubMed Web of Science ®Google Scholar
• Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH. Effects of pentastarch and albumin infusion on cardior-espiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 1989; 17: 391100.
   Google Scholar
• Schuster DP. The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome. New Horiz 1993; 1: 478–88.
   PubMedGoogle Scholar
• Michard F, Boussat S, Chemla D, Anguel N, Mercat A, Lecarpentier Y, et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000; 162: 134–8.
   PubMed Web of Science ®Google Scholar
• Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409–17.
   PubMed Web of Science ®Google Scholar
• Fernandes CJ, Jr., Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001; 5: 362–7.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139–43.
   PubMed Web of Science ®Google Scholar
• Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdy-namic septic shock? Chest 1993; 103: 1826–31.
   Google Scholar
• Marik PE, Mohedia J. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272: 1354–7.
   PubMed Web of Science ®Google Scholar
• Landry DW, Levin FIR, Gallant EM, Ashton RC, Jr., Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilatico of septic shock. Circulation 1997; 95: 1122–5.
   Google Scholar
• Malay MB, Ashton RC, Jr., Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47: 699–703.
   PubMed Web of Science ®Google Scholar
• Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96: 576–82.
   PubMed Web of Science ®Google Scholar
• Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001; 27: 1416–21.
   PubMed Web of Science ®Google Scholar
• Van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJH. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994; 62: 2046–50.
   PubMed Web of Science ®Google Scholar
• Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-a and potenti-ates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713–9.
   PubMed Web of Science ®Google Scholar
• Severn A, Rapsou NT, Hunter CA, Liew FY. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 1992; 148: 3441–5.
   PubMed Web of Science ®Google Scholar
• Uusaro A, Russell JA. Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients? Intensive Care Med 2000; 26: 299–304.
   PubMedGoogle Scholar
• Vincent JL, Roman A, Kahn R J. Dobutamine administration in septic shock: Addition to a standard protocol. Crit Care Med 1990; 18: 689–93.
   PubMed Web of Science ®Google Scholar
• Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC. Increasing splanchnic blood flow in the critically ill. Chest 1995; 108: 1648–54.
   PubMedGoogle Scholar
• Temmesfeld-Wollbruck B, Szalay A, Mayer K, Olschewski H, Seeger W, Grimminger F. Abnormalities of gastric mucosal oxygenation in septic shock: partial responsiveness to dopexamine. Am J Respir Crit Care Med 1998; 157: 1586–92.
   PubMedGoogle Scholar
• Kiefer P, Tugtekin I, Wiedeck H, Bracht H, Geldner G, Georgieff M, et al. Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock. Am J Respir Crit Care Med 2000; 161: 775–9.
   Google Scholar
• Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001; 345: 1359–67.
   PubMed Web of Science ®Google Scholar
• Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, et al. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23: 1430–9.
   PubMed Web of Science ®Google Scholar
• Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27: 723–32.
   Google Scholar
• Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862–71.
   PubMed Web of Science ®Google Scholar
• Schiff H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305–10.
   PubMedGoogle Scholar
• Bellomo R, Ronco C. Blood purification in the intensive care unit: evolving concepts. World J Surg 2001; 25: 677–83.
   PubMed Web of Science ®Google Scholar
• Vincent JL. Sepsis and clinical trials: a new era in anti-sepsis therapies. In: Baue AE, Berlot G, Vincent JL, eds. Sepsis and Organ Dysfunction. Milan: Springer; 2002: 189–96.
   Google Scholar
• Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.
   PubMed Web of Science ®Google Scholar
• Murakami K, Okajima K, Uchiba M, Johno M, Nakagalci T, Okabe H, et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997; 272: L197–202.
   PubMed Web of Science ®Google Scholar
• White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, et al. Activated protein C inhibits lipopolysac-charide-induced nuclear translocation of nuclear factor kap-paB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol 2000; 110: 130–4.
   PubMed Web of Science ®Google Scholar
• Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001; 276: 11199–203.
   PubMed Web of Science ®Google Scholar
• Bulger EM, Arbabi S, Garcia I, Maier RV. The macrophage response to endotoxin requires platelet activating factor. Shock 2002; 17: 173–9.
   PubMedGoogle Scholar
• Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999; 96: 14541–6.
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–51.
   PubMed Web of Science ®Google Scholar
• Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164–70.
   PubMed Web of Science ®Google Scholar
• Appoloni O, Dupont E, Andrien M, Duchateau J, Vincent JL. Association of TNF2, a TNEce promoter polymorphism, with plasma TNFa levels and mortality in septic shock. Am J Med 2001; 110: 486–8.
   PubMedGoogle Scholar
• Carmel S, Rowan K. Variation in intensive care unit outcomes: a search for the evidence on organizational factors. Curr Opin Crit Care 2001; 7: 284–96.
   PubMedGoogle Scholar
• Holcomb BW, Wheeler AP, Ely EW. New ways to reduce unnecessary variation and improve outcomes in the intensive care unit. Curr Opin Crit Care 2001; 7: 304–11.
   PubMedGoogle Scholar
• Pronovost PJ, Miller MR, Dorman T, Berenholtz SM, Rubin H. Developing and implementing measures of quality of care in the intensive care unit. Curr Opin Crit Care 2001; 7: 297–303.
   PubMedGoogle Scholar
• Pronovost PJ, Waters H, Dorman T. Impact of critical care physician workforce for intensive care unit physician staffing. Curr Opin Crit Care 2001; 7: 456–9.
   PubMedGoogle Scholar
• Randolph AG, Pronovost P. Reorganizing the delivery of intensive care could improve efficiency and save lives. J Eval Clin Pract 2002; 8: 1–8.
   PubMedGoogle Scholar